EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inflammatory Prognostic Index: A Novel Predictor of In-Stent Restenosis Following Drug-Eluting Stent–Percutaneous Coronary Intervention

Cemre Turgul, Saban Kelesoglu iD

Diagnostics · 24.02.2026 · 16 (5) · 647

DOI: 10.3390/diagnostics16050647 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 24.02.2026. Verfasst von Cemre Turgul und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University of Health Sciences, Kayseri City Training and Research Hospital, Kayseri 38 000, Turkey. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Inflammatory Prognostic Index (IPI) is a novel biomarker integrating C-reactive protein (CRP), albumin, and white blood cell-derived ratios, reflecting systemic inflammation and nutritional status. Inflammation is central to in-stent restenosis (ISR). This study investigated the prognostic value of IPI in predicting ISR after drug-eluting stent (DES) implantation.

Methods

We retrospectively analyzed 571 patients who underwent DES implantation and follow-up angiography at a median of 12 months (IQR 12–24) for recurrent angina or ischemia. Patients were grouped as ISR (+) (n = 218) and ISR (−) (n = 353). IPI was calculated as (CRP × neutrophil-to-lymphocyte ratio)/albumin. Logistic regression and ROC analyses assessed the predictive role of IPI.

Results

ISR occurred in 38.1% of patients. The ISR (+) group showed a higher prevalence of hypertension and active smoking, as well as higher CRP, glucose, and neutrophil levels, but lower albumin and lymphocytes (all p < 0.05). Elevated IPI independently predicted ISR (OR = 2.90; 95% CI = 2.35–3.57; p < 0.001). ROC analysis showed an optimal cutoff of 1.275 (sensitivity 84.4%, specificity 74.5%).

Conclusions

IPI, derived from routine laboratory tests, independently predicts ISR after DES implantation and may serve as a simple, inexpensive biomarker for coronary artery disease risk stratification.

Schlagwörter

Stichwörter der Autor:innen

C-reactive proteincoronary artery diseasedrug-eluting stentin-stent restenosisinflammatory prognostic indexneutrophil-to-lymphocyte ratio

Autor:innen und Institutionen

  • Department of Cardiology, University of Health Sciences, Kayseri City Training and Research Hospital, Kayseri 38 000, Turkey.
  • Department of Cardiology, Erciyes University Faculty of Medicine, Kayseri 38 000, Turkey.

ORCID-Profile: Saban Kelesoglu

Zitieren

APA

Turgul, C., & Kelesoglu, S. (2026). Inflammatory Prognostic Index: A Novel Predictor of In-Stent Restenosis Following Drug-Eluting Stent–Percutaneous Coronary Intervention. Diagnostics, 16(5), 647. https://doi.org/10.3390/diagnostics16050647

Vancouver

Turgul C, Kelesoglu S. Inflammatory Prognostic Index: A Novel Predictor of In-Stent Restenosis Following Drug-Eluting Stent–Percutaneous Coronary Intervention. Diagnostics. 2026;16(5):647. doi:10.3390/diagnostics16050647

BibTeX
@article{Turgul2026,
  author = {Turgul, Cemre and Kelesoglu, Saban},
  title = {Inflammatory Prognostic Index: A Novel Predictor of In-Stent Restenosis Following Drug-Eluting Stent–Percutaneous Coronary Intervention},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {5},
  pages = {647},
  doi = {10.3390/diagnostics16050647}
}
Kostenlos starten →